| 9145407 |
Sulfonamide compounds |
Christopher John Markworth, Brian Edward Marron, Robert Ian Storer, Nigel Alan Swain, Christopher William West +1 more |
2015-09-29 |
$193,164,000 |
| 9102621 |
Acyl sulfonamide compounds |
Alan Daniel Brown, Robert Ian Storer, Nigel Alan Swain |
2015-08-11 |
$633,506,000 |
| 9096500 |
Acyl sulfonamide compounds |
Alan Daniel Brown, Robert Ian Storer, Nigel Alan Swain |
2015-08-04 |
$291,791,000 |
| 9096558 |
N-sulfonylbenzamide compounds |
Benjamin Scott Greener, Brian Edward Marron, David S. Millan, Robert Ian Storer, Nigel Alan Swain |
2015-08-04 |
$291,791,000 |
| 9085517 |
Sulfonamide derivatives |
Robert Ian Storer, Nigel Alan Swain |
2015-07-21 |
$592,689,000 |
| 8907101 |
Sulfonamide derivatives |
Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David S. Millan +7 more |
2014-12-09 |
$643,454,000 |
| 8772293 |
Chemical compounds |
Alan Daniel Brown, Marcel John De Groot, Brian Edward Marron, Thomas Ryckmans, Robert Ian Storer +3 more |
2014-07-08 |
$296,854,000 |
| 8772343 |
Chemical compounds |
Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Manuel Perez-Pacheco, Robert Ian Storer +1 more |
2014-07-08 |
$296,854,000 |
| 8685977 |
Chemical compounds |
Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, David S. Millan +6 more |
2014-04-01 |
$235,129,000 |
| 8592629 |
Sulfonamide derivatives as Nav 1.7 inhibitors |
Andrew Simon Bell, Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh +6 more |
2013-11-26 |
$220,822,000 |
| 8541588 |
Sulfonamide derivatives |
Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David S. Millan +7 more |
2013-09-24 |
$306,953,000 |
| 8153814 |
Sulfonamide derivatives |
Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David S. Millan +7 more |
2012-04-10 |
$582,544,000 |
| 7659305 |
Therapeutic proline derivatives |
— |
2010-02-09 |
$431,241,000 |
| 7649004 |
Pyridine derivatives |
Charlotte Alice Louise Lane, Graham Nigel Maw, Lisa Rosemary Thompson |
2010-01-19 |
$279,046,000 |
| 7612226 |
Amino acid derivatives |
Shelley Rene Graham, Simon John Mantell, Jacob Bradely Schwarz |
2009-11-03 |
$488,240,000 |
| 7507742 |
Spirocyclic derivatives |
Nigel Alan Swain |
2009-03-24 |
$217,987,000 |
| 7084145 |
Triazole compounds useful in therapy |
Robert Duncan Armour, Andrew Douglas Baxter, Justin Stephen Bryans, Kevin Neil Dack, Patrick Stephen Johnson +3 more |
2006-08-01 |
$226,128,000 |
| 7053122 |
Therapeutic use of aryl amino acid derivatives |
Graham Nigel Maw, Lisa Rosemary Thompson |
2006-05-30 |
$141,176,000 |
| 6809200 |
Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof |
Charlotte Moira Norfor Allerton, Christopher Gordon Barber, Keith M. DeVries, Laurence James Harris, Philip Charles Levett +2 more |
2004-10-26 |
$279,762,000 |
| 6770645 |
Pharmaceutically active compounds |
Stephen Martin Denton, Mark Ian Kemp, Sandra Dora Newman |
2004-08-03 |
$333,534,000 |
| 6756373 |
Pharmaceutically active compounds |
Charlotte Moira Norfor Allerton, Christopher Gordon Barber, Graham Nigel Maw |
2004-06-29 |
$204,847,000 |
| 6593332 |
Pharmaceutically active compounds |
Graham Nigel Maw |
2003-07-15 |
$796,847,000 |
| 6586439 |
Pharmaceutically active compounds |
Graham Nigel Maw |
2003-07-01 |
$274,146,000 |
| 6440982 |
Pharmaceutically active compounds |
Graham Nigel Maw |
2002-08-27 |
$152,025,000 |
| 6384070 |
Indole derivatives useful as endothelin receptor antagonists |
Kevin Neil Dack, Roger P. Dickinson, Kim James |
2002-05-07 |
$456,476,000 |
